Skip to main content

Table 1 Characteristics of the patients with HA

From: Treatment regimens, patient reported outcomes and health-related quality of life in children with moderate and severe hemophilia A in China: using real-world data

Characteristic

All patients, n = 373

On-demand treatment, n = 82

short-term prophylaxis treatment, n = 273

long-term prophylaxis treatment, n = 18

n (%)

373(100.0)

82(22.0)

273(73.2)

18(4.8)

Age groups, n (%)

    

 Mean

7.3

7.2

7.3

7.3

 0–4

136(36.5)

31(37.8)

102(37.4)

3(16.7)

 5–9

116(31.1)

21(25.6)

84(30.8)

11(61.1)

 10–14

90(24.1)

21(25.6)

66(24.2)

3(16.7)

 15–18

31(8.3)

9(11.0)

21(7.7)

1(5.6)

BMI, n (%)

    

 Underweight

162(43.4)

40(48.8)

114(41.8)

8(44.4)

 Normal

154(41.0)

30(36.6)

116(42.5)

7(38.9)

 Overweight

58(15.6)

12(14.6)

43(15.8)

3(16.7)

Social health insurance, n (%)

    

 Yes

360(96.5)

78(95.1)

264(96.7)

18(100.0)

 No

13(3.5)

4(4.9)

9(3.3)

0(0.0)

Regional location, n (%)

    

 East area

173(46.4)

36(43.9)

124(45.4)

13(72.2)

 Mid area

95(25.5)

15(18.3)

77(28.2)

3(16.7)

 West area

105(28.2)

31(37.8)

72(26.4)

2(11.1)

Hemophilia severity, n (%)

    

 Moderate

111(29.8)

31(37.8)

73(26.7)

7(38.9)

 Severe

260(69.7)

50(61.0)

199(72.9)

11(61.1)

 Missing

2(0.5)

1(1.2)

1(0.4)

0(0.0)

Infectious blood disease, n (%)

    

 No

352(94.4)

76(92.7)

258(94.5)

18(100.0)

 Yes

18(4.8)

6(7.3)

12(4.4)

0(0.0)

 Unknown

3(0.8)

0(0.0)

3(1.1)

0(0.0)